523 related articles for article (PubMed ID: 16054174)
1. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Yan QJ; Rammal M; Tranfaglia M; Bauchwitz RP
Neuropharmacology; 2005 Dec; 49(7):1053-66. PubMed ID: 16054174
[TBL] [Abstract][Full Text] [Related]
2. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
[TBL] [Abstract][Full Text] [Related]
3. Group I metabotropic glutamate receptor antagonists alter select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Perkins JR; Yuva-Paylor LA; Paylor R
Psychopharmacology (Berl); 2012 Jan; 219(1):47-58. PubMed ID: 21656124
[TBL] [Abstract][Full Text] [Related]
4. Subchronic administration and combination metabotropic glutamate and GABAB receptor drug therapy in fragile X syndrome.
Pacey LK; Tharmalingam S; Hampson DR
J Pharmacol Exp Ther; 2011 Sep; 338(3):897-905. PubMed ID: 21636656
[TBL] [Abstract][Full Text] [Related]
5. Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
Thomas AM; Bui N; Graham D; Perkins JR; Yuva-Paylor LA; Paylor R
Behav Brain Res; 2011 Oct; 223(2):310-21. PubMed ID: 21571007
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice.
Gantois I; Pop AS; de Esch CE; Buijsen RA; Pooters T; Gomez-Mancilla B; Gasparini F; Oostra BA; D'Hooge R; Willemsen R
Behav Brain Res; 2013 Feb; 239():72-9. PubMed ID: 23142366
[TBL] [Abstract][Full Text] [Related]
7. Rescue of Fmr1
Westmark PR; Dekundy A; Gravius A; Danysz W; Westmark CJ
Neurobiol Dis; 2018 Nov; 119():190-198. PubMed ID: 30125640
[TBL] [Abstract][Full Text] [Related]
8. Fragile X mice have robust mGluR5-dependent alterations of social behaviour in the Automated Tube Test.
de Esch CE; van den Berg WE; Buijsen RA; Jaafar IA; Nieuwenhuizen-Bakker IM; Gasparini F; Kushner SA; Willemsen R
Neurobiol Dis; 2015 Mar; 75():31-9. PubMed ID: 25562659
[TBL] [Abstract][Full Text] [Related]
9. Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.
de Vrij FM; Levenga J; van der Linde HC; Koekkoek SK; De Zeeuw CI; Nelson DL; Oostra BA; Willemsen R
Neurobiol Dis; 2008 Jul; 31(1):127-32. PubMed ID: 18571098
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Jacquemont S; Curie A; des Portes V; Torrioli MG; Berry-Kravis E; Hagerman RJ; Ramos FJ; Cornish K; He Y; Paulding C; Neri G; Chen F; Hadjikhani N; Martinet D; Meyer J; Beckmann JS; Delange K; Brun A; Bussy G; Gasparini F; Hilse T; Floesser A; Branson J; Bilbe G; Johns D; Gomez-Mancilla B
Sci Transl Med; 2011 Jan; 3(64):64ra1. PubMed ID: 21209411
[TBL] [Abstract][Full Text] [Related]
11. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome.
Ronesi JA; Collins KA; Hays SA; Tsai NP; Guo W; Birnbaum SG; Hu JH; Worley PF; Gibson JR; Huber KM
Nat Neurosci; 2012 Jan; 15(3):431-40, S1. PubMed ID: 22267161
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome.
Osterweil EK; Krueger DD; Reinhold K; Bear MF
J Neurosci; 2010 Nov; 30(46):15616-27. PubMed ID: 21084617
[TBL] [Abstract][Full Text] [Related]
13. Selective Disruption of Metabotropic Glutamate Receptor 5-Homer Interactions Mimics Phenotypes of Fragile X Syndrome in Mice.
Guo W; Molinaro G; Collins KA; Hays SA; Paylor R; Worley PF; Szumlinski KK; Huber KM
J Neurosci; 2016 Feb; 36(7):2131-47. PubMed ID: 26888925
[TBL] [Abstract][Full Text] [Related]
14. Absence of metabotropic glutamate receptor-mediated plasticity in the neocortex of fragile X mice.
Wilson BM; Cox CL
Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2454-9. PubMed ID: 17287348
[TBL] [Abstract][Full Text] [Related]
15. Increased GABA(B) receptor-mediated signaling reduces the susceptibility of fragile X knockout mice to audiogenic seizures.
Pacey LK; Heximer SP; Hampson DR
Mol Pharmacol; 2009 Jul; 76(1):18-24. PubMed ID: 19351745
[TBL] [Abstract][Full Text] [Related]
16. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
[TBL] [Abstract][Full Text] [Related]
17. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.
Silverman JL; Tolu SS; Barkan CL; Crawley JN
Neuropsychopharmacology; 2010 Mar; 35(4):976-89. PubMed ID: 20032969
[TBL] [Abstract][Full Text] [Related]
18. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
Nakamoto M; Nalavadi V; Epstein MP; Narayanan U; Bassell GJ; Warren ST
Proc Natl Acad Sci U S A; 2007 Sep; 104(39):15537-42. PubMed ID: 17881561
[TBL] [Abstract][Full Text] [Related]
19. Functional rescue of excitatory synaptic transmission in the developing hippocampus in Fmr1-KO mouse.
Meredith RM; de Jong R; Mansvelder HD
Neurobiol Dis; 2011 Jan; 41(1):104-10. PubMed ID: 20817093
[TBL] [Abstract][Full Text] [Related]
20. Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
Su T; Fan HX; Jiang T; Sun WW; Den WY; Gao MM; Chen SQ; Zhao QH; Yi YH
Psychopharmacology (Berl); 2011 May; 215(2):291-300. PubMed ID: 21181121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
